The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Attempts by defense attorneys for the Raleigh County pharmacist accused of murdering her husband to exclude from trial the ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

Michael Cochran's friends said his wife gave a range of conflicting stories to explain Michael's sudden unresponsive state on ...

28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly) 28 days Prescribing information NPH, human insulin isophane suspension (rDNA origin) Novolin N vial (Novo ...

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a ...

Witness testimony is continuing in the trial for Natalie Cochran, a former Beckley pharmacist and convicted white-collar ...

When you have diabetes, insulin is vital to help keep your blood sugar levels in check. If you have type 1 diabetes, you must inject insulin daily. Those with type 2 diabetes may also require ...

Equities researchers at Leerink Partnrs decreased their FY2024 earnings per share estimates for shares of Eli Lilly and ...